PreCardia today said it received FDA breakthrough device designation for its catheter-based system that treats volume overload in patients with acutely decompensated heart failure. The PreCardia system is designed to rapidly and effectively reduce congestion in the venous system to improve overall cardiorenal function. Patient benefits can … [Read more...] about PreCardia receives FDA breakthrough device designation for catheter-based heart failure treatment
